{"title":"影响沙利度胺治疗输血依赖性地中海贫血疗效和安全性的因素","authors":"晓琳 戴","doi":"10.12677/acm.2023.13112388","DOIUrl":null,"url":null,"abstract":"Thalidomide has achieved clinical efficacy as an HbF inducer in the treatment of transfu-sion-dependent thalassaemia (TDT), but concerns have been raised about its side effects of conti-*","PeriodicalId":7237,"journal":{"name":"Advances in Clinical Medicine","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors Influencing the Efficacy and Safety of Thalidomide in the Treatment of Transfusion-Dependent Thalassaemia\",\"authors\":\"晓琳 戴\",\"doi\":\"10.12677/acm.2023.13112388\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Thalidomide has achieved clinical efficacy as an HbF inducer in the treatment of transfu-sion-dependent thalassaemia (TDT), but concerns have been raised about its side effects of conti-*\",\"PeriodicalId\":7237,\"journal\":{\"name\":\"Advances in Clinical Medicine\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Clinical Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12677/acm.2023.13112388\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12677/acm.2023.13112388","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Factors Influencing the Efficacy and Safety of Thalidomide in the Treatment of Transfusion-Dependent Thalassaemia
Thalidomide has achieved clinical efficacy as an HbF inducer in the treatment of transfu-sion-dependent thalassaemia (TDT), but concerns have been raised about its side effects of conti-*
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
